JPH03503844A - Lak細胞サイトトキシン - Google Patents

Lak細胞サイトトキシン

Info

Publication number
JPH03503844A
JPH03503844A JP1505214A JP50521489A JPH03503844A JP H03503844 A JPH03503844 A JP H03503844A JP 1505214 A JP1505214 A JP 1505214A JP 50521489 A JP50521489 A JP 50521489A JP H03503844 A JPH03503844 A JP H03503844A
Authority
JP
Japan
Prior art keywords
lcc
cells
cytokine
cell
pbmc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1505214A
Other languages
English (en)
Japanese (ja)
Inventor
ハース,エバン エム
スカデリー,フイリツプ ジユニア
グリムス,ウイリアム
サモン,シドニー イー
Original Assignee
リサーチ コーポレーシヨン テクノロジーズ インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by リサーチ コーポレーシヨン テクノロジーズ インコーポレーテツド filed Critical リサーチ コーポレーシヨン テクノロジーズ インコーポレーテツド
Publication of JPH03503844A publication Critical patent/JPH03503844A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP1505214A 1988-04-15 1989-04-05 Lak細胞サイトトキシン Pending JPH03503844A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18187088A 1988-04-15 1988-04-15
US181,870 1988-04-15

Publications (1)

Publication Number Publication Date
JPH03503844A true JPH03503844A (ja) 1991-08-29

Family

ID=22666155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1505214A Pending JPH03503844A (ja) 1988-04-15 1989-04-05 Lak細胞サイトトキシン

Country Status (3)

Country Link
EP (1) EP0409901A4 (fr)
JP (1) JPH03503844A (fr)
WO (1) WO1989009831A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0440742B1 (fr) * 1988-10-27 1997-01-15 The Regents Of The University Of Minnesota Immunoadjuvants liposomiques contenant de l'il-2
EP0578740A4 (en) * 1991-04-05 1995-12-20 Univ Minnesota Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
US5725855A (en) * 1991-04-05 1998-03-10 The United States Of America As Represented By The Department Of Health And Human Services Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
IE922233A1 (en) * 1991-07-10 1993-01-13 Augusto C Ochoa Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
JPH07502734A (ja) * 1991-12-31 1995-03-23 ザイモジェネティクス,インコーポレイティド 血液損失を減少する方法および組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha

Also Published As

Publication number Publication date
EP0409901A4 (en) 1991-10-30
WO1989009831A1 (fr) 1989-10-19
EP0409901A1 (fr) 1991-01-30

Similar Documents

Publication Publication Date Title
JPH05504554A (ja) 免疫強化を促進するための方法と組成物
CN107034235A (zh) 联合靶向pd‑1及egfr的嵌合性抗原t细胞肿瘤免疫方法
JPH013128A (ja) 二官能性抗体構造体及び細胞集団を選択的に破壊する方法
JP2008278889A (ja) 抗cx3cr1抗体、抗フラクタルカイン抗体及びフラクタルカインの利用
JPH06501456A (ja) 表面複合リンホトキシン
ES2327611T3 (es) Empleo de antucuerpos monoclonales especificos de cd28 para estimular celulas sanguineas sin cd28.
Okuno et al. Natural cytotoxic (NC) cell activity in basophilic cells: release of NC-specific cytotoxic factor by IgE receptor triggering.
WO2022222846A1 (fr) Récepteur antigénique chimérique ciblant cd19, son procédé de préparation et son utilisation
US5643740A (en) Monoclonal antibody specific for activated lymphocytes and monocytes
US4758549A (en) Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
US8394368B2 (en) Method for producing a composition for promoting survival of transplanted hematopoietic stem cell
EP0149751A2 (fr) Substance protéinique ayant une action antitumorale et son procédé de préparation
JP4263391B2 (ja) 抗cx3cr1抗体、抗フラクタルカイン抗体及びフラクタルカインの利用
JPH03503844A (ja) Lak細胞サイトトキシン
JPH05503098A (ja) セプシスの処理のためのサイトカイン抗体
JPH03505211A (ja) 好酸球増加症の予防または鎮静用薬剤
US5330896A (en) Monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells
KR930004596B1 (ko) 신규 림포킨(lymphokine) 및 이에 대해 특이성을 갖는 모노클로날(monoclonal) 항체의 제조 방법
CA1340437C (fr) Recepteur de l'interleukine-2 et applications connexes
JP2564245B2 (ja) ロイコレギュリン細胞表面レセプターに特異的なモノクローナル抗体、その製造法、及びその使用
JPH05509318A (ja) インターロイキン―4とインターロイキン―1βが共働してVCAM―1を誘導する
JPS60208924A (ja) ヒト腫瘍壊死因子に対する抗体
EP0311438B1 (fr) Antigène capable de se lier à des cellules tumorales
Simone Directed effector cells selectively lyse human tumour cells
JPS59135898A (ja) 抗原特異的ヒト免疫グロブリンの生産方法